Record title
Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
Record identifier
TN_cdi_hal_primary_oai_HAL_hal_03574345v1
Record permalink
https://collection.sl.nsw.gov.au/record/TN_cdi_hal_primary_oai_HAL_hal_03574345v1
Share
Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
About this item
Full title
Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
Author / Creator
Publisher
United States: Massachusetts Medical Society
Journal title
The New England journal of medicine, 2020, Vol.382 (20), p.1894-1905
Record Identifier
TN_cdi_hal_primary_oai_HAL_hal_03574345v1
Language
English
Formats
Publication information
Publisher
Subjects
More information
Scope and Contents
Contents
Alternative Titles
Full title
Authors, Artists and Contributors
Author / Creator
IMbrave150 Investigators
Finn, Richard S
Qin, Shukui
Ikeda, Masafumi
Galle, Peter R
Ducreux, Michel
Kim, Tae-You
Kudo, Masatoshi
Breder, Valeriy
Merle, Philippe
Kaseb, Ahmed O
Li, Daneng
Verret, Wendy
Xu, Derek-Zhen
Hernandez, Sairy
Liu, Juan
Huang, Chen
Mulla, Sohail
Wang, Yulei
Lim, Ho Yeong
Zhu, Andrew X
Cheng, Ann-Lii
Finn, Richard S
Qin, Shukui
Ikeda, Masafumi
Galle, Peter R
Ducreux, Michel
Kim, Tae-You
Kudo, Masatoshi
Breder, Valeriy
Merle, Philippe
Kaseb, Ahmed O
Li, Daneng
Verret, Wendy
Xu, Derek-Zhen
Hernandez, Sairy
Liu, Juan
Huang, Chen
Mulla, Sohail
Wang, Yulei
Lim, Ho Yeong
Zhu, Andrew X
Cheng, Ann-Lii
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_hal_primary_oai_HAL_hal_03574345v1
Permalink
https://collection.sl.nsw.gov.au/record/TN_cdi_hal_primary_oai_HAL_hal_03574345v1
Other Identifiers
ISSN
E-ISSN
DOI
